References
- American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 778–785, [CSA]
- American Academy of Neurology AIDS Task Force. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 1996; 47: 1247–1253, [CSA]
- Bernal G, Bonilla J, et al. Confiabilidad interna y validez de construcción lógica de dos instrumentos para medir sintomatología psicológica en una muestra clínica: El inventario de depresión Beck y la Lista de Cotejo de Síntomas. Rev Latinoamericana Psicol 1995; 27: 207–229, [CSA]
- Bonilla J, Bernal G, et al. A revised Spanish version of the Beck Depression Inventory: psychometric properties with a Puerto Rican sample of college students. J Clin Psychol 2004; 60: 119–130, [INFOTRIEVE], [CSA], [CROSSREF]
- CDC. 2003, HIV/AIDS Surveillance Report
- CDC. 2004, HIV/AIDS Surveillance Report
- Chiesi A, Vella S, et al. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11: 39–44, [INFOTRIEVE], [CSA]
- Clark R A, Bessinger R. Clinical manifestations and predictors of survival in older women infected with HIV. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 341–345, [INFOTRIEVE], [CSA]
- Cysique L A, Maruff P, et al. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre-and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J NeuroVirol 2004; 10: 350–357, [INFOTRIEVE], [CSA]
- Davis T M, Rodriguez V L. Comparison of scores on the WAIS and its Puerto Rican counterpart, Escala de Inteligencia Wechsler para Adultos, in an institutionalized Latin American psychiatric population. J Consult Clin Psychol 1979; 47: 181–182, [INFOTRIEVE], [CSA], [CROSSREF]
- Demsky Y I, Gass C S, et al. Interpretation of VIQ-PIQ and intersubtest differences on the Spanish version of the WAIS. Assessment 1998; 5: 25–30, [INFOTRIEVE], [CSA]
- Dore G J, Correll P K, et al. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999; 23: 1249–1253, [CSA], [CROSSREF]
- Dore G J, McDonald A, et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17: 1539–1545, [INFOTRIEVE], [CSA], [CROSSREF]
- Durvasula R S, Miller E N, et al. Predictors of neuropsychological performance in HIV positive women. J Clin Exp Neuropsychol 2001; 23: 149–163, [INFOTRIEVE], [CSA]
- Farzadegan H, Hoover D R, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998; 352: 1510–1514, [INFOTRIEVE], [CSA], [CROSSREF]
- Galli M, Veglia F, et al. Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 2003; 34: 58–61, [INFOTRIEVE], [CSA], [CROSSREF]
- Gange S J, Barron Y, et al. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J Epidemiol Community Health 2002; 56: 153–159, [INFOTRIEVE], [CSA], [CROSSREF]
- Gardner A, Pande K C. Graf ligamentoplasty: a 7-year follow-up. Eur Spine J 2002; 11(Suppl 2)S157–S163, [INFOTRIEVE], [CSA]
- Hilditch J R, Lewis J, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996; 24: 161–175, [INFOTRIEVE], [CSA]
- Inungu J N, Mokotoff E D, et al. Characteristics of HIV infection in patients fifty years or older in Michigan. AIDS Patient Care STDS 2001; 15: 567–573, [INFOTRIEVE], [CSA], [CROSSREF]
- Janssen R S, Cornblath D R, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection: report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 778, [CSA]
- Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurgr Psychiatry 2000; 69: 376–380, [CSA], [CROSSREF]
- McArthur J C. HIV dementia: an evolving disease. J Neuroimmunol 2004; 157: 3–10, [INFOTRIEVE], [CSA], [CROSSREF]
- McArthur J C, Brew B J, et al. Neurological complications of HIV infection. Lancet Neurol 2005; 4: 543–555, [INFOTRIEVE], [CSA], [CROSSREF]
- McArthur J C, Cohen B A, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study. Ann Neurol 1989; 26: 601–611, [INFOTRIEVE], [CSA], [CROSSREF]
- McArthur J C, Haughey N, et al. Human immunodeficiency virus-associated dementia: an evolving disease. J NeuroVirol 2003; 9: 205–221, [INFOTRIEVE], [CSA]
- McArthur J C, Sacktor N, et al. Human immunodeficiency virus-associated dementia. Sem Neurol 1999; 19: 129–150, [CSA]
- Moore A L, Mocroft A, et al. Gender differences in virologic response to treatment in an HIV-positive population: a cohort study. J Acquir Immune Defic Syndr 2001; 26: 159–163, [INFOTRIEVE], [CSA], [CROSSREF]
- Morgello S, Mahboob R, et al. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med 2002; 126: 182–190, [INFOTRIEVE], [CSA]
- Ojikutu B O, Stone V E. Women, inequality, and the burden of HIV. N Engl J Med 2005; 352: 649–652, [INFOTRIEVE], [CSA], [CROSSREF]
- Poundstone K E, Chaisson R E, et al. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS 2001; 15: 1115–1123, [INFOTRIEVE], [CSA], [CROSSREF]
- PRAIDS-Surveillance. 2005, Puerto Rico AIDS Surveillance Report
- Prins M, Robertson J, et al. Do gender differences in CD4 cell count matter?. AIDS 1999; 13: 2361–2364, [INFOTRIEVE], [CSA], [CROSSREF]
- Quinn T C, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 2005; 308: 1582–1583, [INFOTRIEVE], [CSA], [CROSSREF]
- Reger M, Welsh R, et al. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 2002; 8: 410–424, [INFOTRIEVE], [CSA], [CROSSREF]
- Richardson J L, Martin E M, et al. Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy. J Int Neuropsychol Soc 2002; 8: 781–93, [INFOTRIEVE], [CSA], [CROSSREF]
- Robertson K R, Kapoor C, et al. No gender differences in the progression of nervous system disease in HIV infection. J Acquir Immune Defic Syndr 2004; 36: 817–822, [INFOTRIEVE], [CSA]
- Ryan E, Baird R, et al. Neuropshological impairment in racial/ethnic minorities with HIV infection and low literacy levels: effects of education and reading level in participant characterization. J Int Neuropsychol Soc 2005; 11: 889–898, [INFOTRIEVE], [CSA]
- Saada M, Le Chenadec J, et al. Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS 2000; 14: 2355–2360, [INFOTRIEVE], [CSA], [CROSSREF]
- Sacktor N, Lyles R H, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 2001; 56: 257–260, [INFOTRIEVE], [CSA]
- Sacktor N, McDermott M P, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 2002; 8: 136–142, [INFOTRIEVE], [CSA]
- Schifitto G, Kieburtz K, et al. Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology 2001; 56: 415–418, [INFOTRIEVE], [CSA]
- Selnes O A. Memory loss in persons with HIV/AIDS: assessment and strategies for coping. AIDS Read 2005; 15: 289–292, 294[INFOTRIEVE], [CSA]
- Selnes O A, McArthur J C, et al. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992; 42: 1924–1930, [INFOTRIEVE], [CSA]
- Selnes O A, Miller E, et al. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study. Neurology 1990; 40: 204–208, [INFOTRIEVE], [CSA]
- Tozzi V, Balestra P, et al. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J NeuroVirol 2005; 11: 265–273, [INFOTRIEVE], [CSA], [CROSSREF]
- UNAIDS. Caribbean Fact Sheet. 2004a
- UNAIDS, UNFPA, et al. Women and HIV/AIDS: Confronting the Crisis. 2004b
- Valcour V, Shikuma C, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 2004; 63: 822–827, [INFOTRIEVE], [CSA]
- Watts D H, Lambert J, et al. Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 2003; 33: 585–593, [INFOTRIEVE], [CSA]
- Welch K, Morse A. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy. AIDS Patient Care STDS 2002; 16: 75–81, [INFOTRIEVE], [CSA], [CROSSREF]